SingleTimeMicroneedles Wins at 2024 SXSW Pitch Competition

SingleTimeMicroneedles, Inc., a pioneering microneedle drug development and delivery firm, clinched victory in the Food, Nutrition, and Health category at the 15th annual SXSW Pitch competition. In an event primarily overwhelmed by AI innovations, STM's distinctive approach marked a significant departure.

At the South by Southwest® Conference & Festivals, STM, led by CEO Jasdeep Singh, showcased its technology to a live audience and a panel of judges, triumphing over immense competition. Singh impressed the jury with his detailed answers and compelling narratives, emphasizing the company's mission to radically enhance health worldwide.

STM's groundbreaking microneedle delivery platform introduces a revolutionary method for administering drugs and vaccines, eliminating the need for cold-chain storage and enabling immediate or scheduled doses. This innovation has vast potential for both animal and human health applications, promising to transform access to critical pharmaceuticals globally.

Reflecting on the win, Research Lead Nicholas Farrell highlighted the significance of STM's achievement at SXSW, attributing their success to Singh's effective communication of the technology's global impact potential.

Following this victory, SingleTimeMicroneedles is poised for rapid growth, seeking partnerships to further its mission in the global health sector.